361 Capital’s Exelixis EXEL Stock Holding History

361 Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-29,568	Closed	-$582K	–	347
2018 Q4	$582K	Buy	+29,568	New	+$527K	0.12%	247
2018 Q1	–	Sell	-86,238	Closed	-$2.62M	–	290
2017 Q4	$2.62M	Buy	86,238 +54,466	+171%	+$1.45M	0.65%	24
2017 Q3	$770K	Buy	+31,772	New	+$846K	0.15%	215

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

361 Capital's EXEL Position: Q1 2019 in Review

361 Capital sold out of Exelixis (EXEL) in Q1 2019, closing a stake of 29,568 shares — an estimated $582K sold.

361 Capital first reported a position in EXEL in Q3 2017 and held it in 3 quarters. The position peaked at $2.62M in Q4 2017. 377 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

361 Capital reported no remaining Exelixis position as of Q1 2019 after selling out during the quarter.
361 Capital sold 29,568 Exelixis shares in Q1 2019, an estimated $582K.
361 Capital first reported a position in Exelixis in Q3 2017 and held it in 3 quarters.
361 Capital's Exelixis position peaked at $2.62M in Q4 2017.
377 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on 361 Capital's 13F filing for Q1 2019, filed 7 May 2019.